Non-Hodgkin lymphoma Posts - Page 31 of 44 on Medivizor
Navigation Menu

Non-Hodgkin lymphoma Posts on Medivizor

How does a positive Epstein-Barr virus status or immunosuppression impact outcomes for DLBCL patients?

How does a positive Epstein-Barr virus status or immunosuppression impact outcomes for DLBCL patients?

Posted by on Jan 26, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study analyzed the outcomes of patients with diffuse large B-cell lymphoma (DLBCL) who are positive for Epstein-Barr virus (EBV+) or are immunosuppressed (weakened immune system caused by anticancer treatment). The study concluded that these conditions do not impact lymphoma outcomes. Some background Rates of EBV+ DLBCL (diffuse...

Read More

Effect of weight on patient outcomes for patients with aggressive B-cell lymphomas

Effect of weight on patient outcomes for patients with aggressive B-cell lymphomas

Posted by on Jan 26, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the impact being overweight or obese had on outcomes for elderly patients with B-cell lymphomas. The study concluded that female patients who were obese had worse outcomes than those who were not obese.  Some background Being overweight or obese can have negative effects on health. People who are obese have...

Read More

What is Neutropenia?

What is Neutropenia?

Posted by on Jan 21, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...

Read More

Early stem cell transplantation may improve survival rates for patients with follicular lymphoma whose first-line chemotherapy failed

Early stem cell transplantation may improve survival rates for patients with follicular lymphoma whose first-line chemotherapy failed

Posted by on Jan 13, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effect of autologous stem cell transplantation (auto-SCT) on patients with follicular lymphoma who have disease progression within 2 years of initial chemotherapy. The study found that patients who receive early auto-SCT have better survival rates than patients who do not receive auto-SCT.  Some background...

Read More

New treatment option for patients with relapsed or difficult to treat mantle cell lymphoma: Acalabrutinib

New treatment option for patients with relapsed or difficult to treat mantle cell lymphoma: Acalabrutinib

Posted by on Jan 13, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looks at the effectiveness of acalabrutinib (Calquence) to treat patients with relapsed or refractory mantle cell lymphoma. The study concluded that acalabrutinib is a safe and effective treatment for relapsed or difficult to treat mantle cell lymphoma.  Some background Mantle cell lymphoma (MCL) is an aggressive...

Read More

Is R-CHOP chemotherapy an effective first-line treatment for patients with grade 3 follicular lymphoma?

Is R-CHOP chemotherapy an effective first-line treatment for patients with grade 3 follicular lymphoma?

Posted by on Jan 7, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study analyzed the long-term outcomes of patients with grade 3 follicular lymphoma (FLG3) who received first-line R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). The study concluded that this regimen is an effective first-line treatment for patients with FLG3, especially in those with less...

Read More

How does lymphoma affect the sleep quality and overall quality of life of long-term survivors?

How does lymphoma affect the sleep quality and overall quality of life of long-term survivors?

Posted by on Jan 6, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study analyzed the long-term effects of cancer on sleep quality and health-related quality of life (HRQOL) in 9-year NHL and HL survivors. The study concluded that poor sleep is associated with poor HRQOL. Some background Improvements in detecting and treating cancer have led to declining mortality rates. As the number of cancer...

Read More

How does lymphoma affect the sleep quality and overall quality of life of long-term survivors?

How does lymphoma affect the sleep quality and overall quality of life of long-term survivors?

Posted by on Jan 6, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study analyzed the long-term effects of cancer on sleep quality and health-related quality of life (HRQOL) in 9-year NHL and HL survivors. The study concluded that poor sleep is associated with poor HRQOL. Some background Improvements in detecting and treating cancer have led to declining mortality rates. As the number of cancer...

Read More